Author Archive | Raynovich Rod

Rayno Life Science Portfolio Movers: ALXN, AMRI, CBST

here Rayno Life Science picks had earnings news and overall the Portfolio was up 1%. Albany Molecular (AMRI $3.49) stock was up 5.44% on low volume but showing steady recovery from recent lows in the $3 range. AMRI is a value stock trading at a market cap of $105M with forecasted revenues in the $222M range. […]

Continue Reading 0

Phase 3 Malaria Vaccine Trial Effective: AGEN, GSK

follow url A promising new malaria vaccine from GlaxoSmithKline (GSK $43.72) offers hope to children in Africa.The final stage trial cut the risk of clinical malaria by 56 % and severe malaria by 47%. Malaria killed 781,000 people in 2009 and is a big problem in sub-Sahara Africa. The data was presented at the Bill and Melinda […]

Continue Reading 0